Integration of AI in Medical Communications: A Roadmap
AI in medical communications: Why it matters now Artificial intelligence (AI) is rapidly reshaping medical communications (MedComms), driven by the necessity for personalization, efficiency, and speed in content delivery. As pharmaceutical companies face mounting competition, the demand for innovative communication strategies to communicate complex data and information, as early as the critical pre-launch phase, is…...
Read MoreTop Stories
The Nelson Memo: Igniting a Global Open Data
The landscape of scientific research is undergoing a seismic...
Rare Diseases – An Evolving Medical
A disease is considered rare when it affects fewer than 1 in...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
Pharma, Physician, and Patient Pain Points Regarding Clinical Trials
Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
3 Factors That Will Help Pharma Build Public Trust
Pharma must engage with patients at all levels to build public trust...
Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy
Read an insightful discussion from the latest ISMPP conference on how science communication and medical...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
Plain Language Summary Development in Japan: Current State and Challenges
This page contains supplementary information to support a poster presented at the Virtual 17th Annual...